Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Perry Ellis International Inc. (PERY - Snapshot Report) posted adjusted earnings per share of 71 cents in the first quarter of fiscal 2013, beating the Zacks Consensus Estimate of 65 cents but deteriorating from the year-ago earnings of $1.08 per share. On a reported basis, earnings per share were 64 cents versus 99 cents earned in the year-ago quarter. Perry Ellis' total revenue decreased 7.9% year over year in the quarter to $265.5 million.
During the quarter, Perry Ellis' gross profit declined 9.6% year over year to $87.7 million. Moreover, gross margin fell 60 basis points (bps) to 33.0%. Selling, general and administrative expense increased 4.6% year over year to $66.3 million owing to the expansion of the company’s direct to consumer business in the second half of fiscal 2012 and costs related to exited brands as well as restructuring in the first quarter of fiscal 2013.
Financials
At quarter end, Perry Ellis had cash and cash equivalents of $28.5 million. Total long-term liability was $248.7 million.
Guidance
For full fiscal 2013, Perry Ellis expects revenue from its existing business in the range of $990 million to $1.0 billion. Adjusted earnings per share are expected in the range of $1.95 to $2.00. On a GAAP basis, management expects earnings per share between $1.85 and $1.90.
For the full year, management anticipates gross margin improvement in the range of 70 to 80 bps.
Our Take
Perry Ellis, the designer, distributor and licensor of a broad line of men's and women's apparel, accessories, and fragrances, remains optimistic about the new product assortment for the fall and holiday seasons especially in Rafaella sportswear collections. Management remains committed to growing direct-to-consumer and e-commerce businesses. We believe this is a positive step toward the strength of Perry Ellis’ market share gain. In a faltering economy, the company is streamlining operations and cutting less productive overhead in order to realize cost savings. Moderating prices of cotton and other raw materials is another positive for the company.
Concerns for the near term include wage inflation, promotional markdowns and high amount of debt in the company’s balance sheet. Additionally, most of the company’s initiatives are unlikely to reap benefit before the second half of the year.
Perry Ellis currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock. Perry Ellis' peers include Polo Ralph Lauren Corp. (RL - Analyst Report) and CROCS Inc. (CROX - Snapshot Report).
Get the full Analyst Report on RL - FREE
Get the full Snapshot Report on PERY - FREE
Get the full Snapshot Report on CROX - FREE